» Articles » PMID: 20652980

Prognostic Significance of Nuclear PSTAT3 in Oral Cancer

Overview
Journal Head Neck
Date 2010 Jul 24
PMID 20652980
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Aberrant nuclear accumulation of proteins influences tumor development and may predict biologic aggressiveness and disease prognosis. This study determined the prognostic significance of pSTAT3 (phosphorylayed signal transducer and activator of transcription 3) in oral squamous cell carcinomas (OSCCs).

Methods And Results: Using immunohistochemistry, a significant increase in nuclear accumulation of pSTAT3 was observed in 49 of 90 leukoplakias (54.4%) and 63/94 OSCCs (67%) (p(trend) < .001). Increased pSTAT3 was associated with tumor stage (p = .01), nodal metastasis (p = .0018), and tobacco consumption (p = .004). Kaplan-Meier analysis demonstrated that OSCC with increased nuclear pSTAT3 showed significantly reduced disease-free survival (13 months), compared with the patients with no nuclear pSTAT3 expression (64 months, p = .019). Cox regression analysis revealed nuclear pSTAT3 as the most significant predictor of poor prognosis (p = .024, hazard ratio [HR] = 2.7).

Conclusions: Increased nuclear accumulation of pSTAT3 occurs in early premalignant stages and is a marker for poor prognosis of OSCC.

Citing Articles

A synthetic molecule targeting STAT3 against human oral squamous cell carcinoma cells.

Bai L, Dokla E, Chu P, Feng C, Hu J, Wang L Int J Med Sci. 2025; 22(5):1081-1091.

PMID: 40027184 PMC: 11866527. DOI: 10.7150/ijms.105200.


Ferroptosis-related lncRNAs: Distinguishing heterogeneity of the tumour microenvironment and predicting immunotherapy response in bladder cancer.

Yang Z, Li X, Zhou L, Luo Y, Zhan N, Ye Y Heliyon. 2024; 10(11):e32018.

PMID: 38867969 PMC: 11168393. DOI: 10.1016/j.heliyon.2024.e32018.


Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer-A Step before Anakoinosis-Based Personalized Treatment.

Kleszcz R Cancers (Basel). 2023; 15(17).

PMID: 37686523 PMC: 10486994. DOI: 10.3390/cancers15174247.


Identification of sterile a-motif domain-containing 9-like as a potential biomarker in patients with cutaneous melanoma.

Ye J, Tang H, Xie C, Han W, Shen G, Qian Y PeerJ. 2023; 11:e15634.

PMID: 37426410 PMC: 10329423. DOI: 10.7717/peerj.15634.


Role of chemokine-like factor 1 as an inflammatory marker in diseases.

Li Y, Yu H, Feng J Front Immunol. 2023; 14:1085154.

PMID: 36865551 PMC: 9971601. DOI: 10.3389/fimmu.2023.1085154.